Adenosine Type A2A Receptor in Peripheral Cell from Patients with Alzheimer’s Disease, Vascular Dementia, and Idiopathic Normal Pressure Hydrocephalus: A New/Old Potential Target-Reference-Cited by-同舟云学术

Adenosine Type A2A Receptor in Peripheral Cell from Patients with Alzheimer’s Disease, Vascular Dementia, and Idiopathic Normal Pressure Hydrocephalus: A New/Old Potential Target

Published:2016-09-06 Issue:2 Volume:54 Page:417-425
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Arosio Beatrice¹²,Casati Martina¹³,Gussago Cristina¹,Ferri Evelyn¹³,Abbate Carlo²,Scortichini Valeria²,Colombo Elena¹,Rossi Paolo Dionigi²,Mari Daniela¹²

Affiliation:

1. Geriatric Unit, Department of Medical Sciences and Community Health, University of Milan, Milan, Italy

2. Fondazione Ca’ Granda, IRCCS Ospedale Maggiore Policlinico, Milan, Italy

3. Nutritional Sciences, University of Milan, Milan, Italy

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference91 articles.

1. The cost of brain diseases: A burden or a challenge?;DiLuca;Neuron,2014

2. The Alzheimer myth and biomarker research in dementia;Richard;J Alzheimers Dis,2012

3. The comparison of selected cerebrospinal fluid and serum cytokine levels in patients with multiple sclerosis and normal pressure hydrocephalus;Sosvorova;Neuro Endocrinol Lett,2015

4. The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer’s disease: Agonists or antagonists?;Marzagalli;Neural Regen Res,2015

5. Purine and pyrimidine receptors;Burnstock;Cell Mol Life Sci,2007

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Gladiolus psittascinus Hook bulb supplemented diet on nootropic-related biomolecules in scopolamine-induced cognitive dysfunction rats;Phytomedicine Plus;2023-05

2. Sirolimus relieves seizures and neuropsychiatric symptoms via changes of microglial polarity in tuberous sclerosis complex model mice;Neuropharmacology;2022-11

3. Adenosine A2A Receptors as Biomarkers of Brain Diseases;Frontiers in Neuroscience;2021-07-16

4. Targeting Adenosine Receptors in Neurological Diseases;Cellular Reprogramming;2021-04-01

5. Role of N4-acetylcytidine for continuously activating NLRP3 inflammosome by HMGB1 pathway in microglia;Neural Regeneration Research;2021